Biomerica (BMRA) Cash from Financing Activities (2010 - 2026)

Biomerica has disclosed Cash from Financing Activities across 16 years of filings, most recently posting $61000.0 for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at $61000.0, down 96.49% year-over-year; the trailing twelve-month figure through Feb 2026 was $1.5 million (down 84.4% YoY), and the FY2025 annual result was $2.1 million, up 2706.17% from the prior year.
• Cash from Financing Activities came in at $61000.0 for Q1 2026 at Biomerica, down from $482000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $7.4 million in Q2 2023 to a low of -$5000.0 in Q2 2025.
• The 4-year median for Cash from Financing Activities is $482000.0 (2025), against an average of $1.2 million.
• Across the five-year window, Cash from Financing Activities jumped 19414.14% in 2023 and sank 96.49% in 2026, its largest moves.
• Biomerica's Cash from Financing Activities stood at $237000.0 in 2022, then surged by 3001.27% to $7.4 million in 2023, then plunged by 93.44% to $482000.0 in 2025, then sank by 87.34% to $61000.0 in 2026.
• The last three Cash from Financing Activities figures came in at $61000.0 (Q1 2026), $482000.0 (Q4 2025), and $920000.0 (Q3 2025), per Business Quant data.